Consolidated Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2022	$ (56,624)	$ 111	$ 628,242	$ (684,893)	$ (84)
Beginning balance (in shares) at Dec. 31, 2022		111,492,791
Increase (Decrease) in Stockholders' Equity
Stock compensation expense	1,520		1,520
Vesting of restricted stock units	1	$ 1
Vesting of restricted stock units (in shares)		343,406
Issuance of common stock under employee stock purchase plan	164		164
Issuance of common stock under employee stock purchase plan (in shares)		119,727
Foreign currency translation adjustment	0
(Net loss) income	(18,847)			(18,847)
Ending balance at Mar. 31, 2023	(73,785)	$ 112	629,927	(703,740)	(84)
Ending balance (in shares) at Mar. 31, 2023		111,955,924
Beginning balance at Dec. 31, 2022	(56,624)	$ 111	628,242	(684,893)	(84)
Beginning balance (in shares) at Dec. 31, 2022		111,492,791
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustment	0
(Net loss) income	(16,224)
Ending balance at Jun. 30, 2023	(69,660)	$ 112	631,426	(701,114)	(84)
Ending balance (in shares) at Jun. 30, 2023		112,091,764
Beginning balance at Mar. 31, 2023	(73,785)	$ 112	629,927	(703,740)	(84)
Beginning balance (in shares) at Mar. 31, 2023		111,955,924
Increase (Decrease) in Stockholders' Equity
Stock compensation expense	1,499		1,499
Vesting of restricted stock units (in shares)		135,840
Foreign currency translation adjustment	0
(Net loss) income	2,626			2,626
Ending balance at Jun. 30, 2023	(69,660)	$ 112	631,426	(701,114)	(84)
Ending balance (in shares) at Jun. 30, 2023		112,091,764
Beginning balance at Dec. 31, 2023	$ (86,606)	$ 112	633,742	(720,376)	(84)
Beginning balance (in shares) at Dec. 31, 2023	112,399,495	112,399,495
Increase (Decrease) in Stockholders' Equity
Stock compensation expense	$ 1,456		1,456
Vesting of restricted stock units	1	$ 1
Vesting of restricted stock units (in shares)		478,520
Issuance of common stock under employee stock purchase plan (in shares)		160,711
(Net loss) income	(14,067)			(14,067)
Ending balance at Mar. 31, 2024	(99,216)	$ 113	635,198	(734,443)	(84)
Ending balance (in shares) at Mar. 31, 2024		113,038,726
Beginning balance at Dec. 31, 2023	$ (86,606)	$ 112	633,742	(720,376)	(84)
Beginning balance (in shares) at Dec. 31, 2023	112,399,495	112,399,495
Increase (Decrease) in Stockholders' Equity
Foreign currency translation adjustment
(Net loss) income	(21,649)
Ending balance at Jun. 30, 2024	$ (42,853)	$ 150	699,105	(742,024)	(84)
Ending balance (in shares) at Jun. 30, 2024	149,678,410	149,678,410
Beginning balance at Mar. 31, 2024	$ (99,216)	$ 113	635,198	(734,443)	(84)
Beginning balance (in shares) at Mar. 31, 2024		113,038,726
Increase (Decrease) in Stockholders' Equity
Stock compensation expense	2,735		2,735
Issuance of stock per amended debt agreement	5,750	$ 5	5,745
Issuance of stock per amended debt agreement (in shares)		4,680,000
Proceeds from sales of common stock and warrants, net	55,294	$ 32	55,262
Proceeds from sales of common stock and warrants, net (in shares)		31,800,000
Vesting of restricted stock units (in shares)		159,684
Issuance of common stock under employee stock purchase plan			165
Foreign currency translation adjustment	0
(Net loss) income	(7,581)			(7,581)
Ending balance at Jun. 30, 2024	$ (42,853)	$ 150	$ 699,105	$ (742,024)	$ (84)
Ending balance (in shares) at Jun. 30, 2024	149,678,410	149,678,410